Clinical Trial

A Study of CAR-T Cells Targeting Autoimmune Diseases

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to assess the safety and efficacy of CAR-T cell therapy in patients with autoimmune disease.
Trial Details
NCT Number NCT06661811
Lead Sponsor Beijing Boren Hospital
Conditions Autoimmune Diseases
Enrollment 12 participants
Start Date 2024-11-15
Primary Completion 2028-04-20 (estimated)
Study Completion 2028-06-20 (estimated)
Updated on ClinicalTrials.gov 2024-10-28